Skip to main content
OpenTrials
Completed

NCT Number: NCT01864239

The Medicines Advice Service Evaluation

The purpose of this study is to find out whether talking to a pharmacist on the telephone can help to support people taking medicine for a long-term condition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Dyslipidemias Endocrine System Diseases Glucose Metabolism Disorders Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UCL School of Pharmacy

London, United Kingdom

About this study

Non-adherence to medication is common and although some interventions have shown promise in improving adherence, the findings are inconsistent. This randomised controlled trial aims to test the effectiveness of a pharmacy-based telephone intervention compared to usual care on medication adherence and health outcomes in patients taking medicines for a long-term condition.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients prescribed medication(s) for at least one of the following conditions: type 2 diabetes, hyperlipidemia

Exclusion criteria

  • Patients living outside of England
  • Patients with no access to a telephone
  • Patients under the age of 18
  • Patients unable to give written informed consent
  • Patients on drugs for dementia
  • Patients showing signs of dementia or cognitive impairment in conversation
  • Patients with substantial hearing or sight impairment
  • Patients whose medications are ordered by a caregiver/family member
  • Patients with insufficient English to take part in the telephone intervention
  • Patients living with someone already taking part in the study
  • Patients newly prescribed a medication for the conditions listed in the inclusion criteria

Treatment and study plan

Medicines Advice Service

Other

The intervention consists of:

  • Telephone consultations with a pharmacist
  • Follow-up tailored written information
  • A medicine reminder chart

Primary outcomes

  1. Self-reported medication adherence

    Time frame: 6 months

Secondary outcomes

  1. Prescription refill adherence

    Time frame: Baseline, 6 months and 12 months

  2. Self-reported medicine-related problems and concerns

    Time frame: Baseline, 3 months and 6 months

    Medicine-related problems and concerns will be assessed in a self-report questionnaire.

  3. Beliefs about Medicines

    Time frame: Baseline, 3 months and 6 months

    Beliefs about medicines will be assessed in a self-report questionnaire using the Beliefs About Medicines Questionnaire (BMQ) (Horne et al. 1999).

  4. HbA1c

    Time frame: Baseline and 6 months

  5. Serum Cholesterol Levels

    Time frame: Baseline and 6 months

Sponsors and collaborators

Lead sponsor

University College, London

Other

Collaborators

  • Pharmacy2U

Registry information

Official study title

The Medicines Advice Service: A Randomised Controlled Trial of a Pharmacy-based Telephone Intervention to Support Patients Taking Medication for a Long-term Condition

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
May 29, 2013
Registry last updated
May 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.